Following approval, Medtronic began a Customer Training Phase in March to test the device's real-world use. Those that used the MiniMed 670G remained in a healthy blood glucose range 74% of the time.

Insulin Pump Risks and Benefits A Clinical Appraisal of Pump Safety Standards, Adverse Event Reporting, and Research Needs. A Joint Statement of the European Association for the Study of Diabetes ...

Insulin Pump Risks and Benefits A Clinical Appraisal of Pump Safety Standards, Adverse Event Reporting, and Research Needs. A Joint Statement of the European Association for the Study of Diabetes ...

SPRINGFIELD — Carrie Harrison knew about what diabetics went through physically — she has a brother with type 1 diabetes and had seen him counting carbohydrates and injecting insulin.

The insulin infusion pump market is expected to further boom in the future with projections suggesting a jump to $10.31 billion by 2029, riding a CAGR of 10.2%.

GALWAY, Ireland, June 12, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New Diabetes Company following ...

Analyst Ratings Published 06/18/2025, 11:22 AM 0 Medtronic stock has significant opportunity in renal denervation, RBC says MDT -0.19% ...

The firm started Dexcom (NASDAQ:DXCM), Insulet (NASDAQ:PODD), and Beta Bionics with Buy ratings, while initiating Tandem Diabetes Care (NASDAQ:TNDM) at Hold. Truist already covers Medtronic’s diabetes ...

Investing.com -- Truist Securities launched coverage on four diabetes technology companies, saying there is a long-term growth potential for continuous glucose monitors (CGM) and insulin pumps amid ...

By the Journal Star editorial board Jul 6, 2013 Updated Jan 28, 2015 0 ...

The Simplici-T Annuloplasty System offers a first-of-its-kind approach to mitral and tricuspid valve repair. It is the first flexible band to eliminate the need for traditional sizing, providing a ...